Highly Active Antiretroviral Therapy Reduces Mortality and Morbidity in Patients with AIDS in Sungai Buloh Hospital

Journal of Experimental and Clinical Medicine

Volumn 4, Issue 4, 2012, Pages 239-244

  Mat Shah, Rozaini ^a   Bulgiba, Awang ^b   Lee, Christopher K C ^c   Haniff, Jamaiyah ^d   Mohamad Ali, Mariana ^d  

^a Southern Seberang Perai District Health Office   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c HOSPITAL SUNGAI BULOH   (Malaysia)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

Author keywords

AIDS; AIDS mortality rate; Highly active antiretroviral therapy; Human immunodeficiency virus; Malaysia

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; FEMALE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXTENSION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT DURATION;

EID: 84865803035     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2012.06.011     Document Type: Article

References (22)

1. Mulcahy F., Hoffman C. ART 2006. Perspective in HIV medicine 2006 2006, 89-93. Flying Publisher, Paris. C. Hoffman, J.K. Rockstroh, B.S. Kamps (Eds.).
2. Kirk O. Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomized and observational studies. Dan Med Bull 2004, 51:63-81.
3. Hammer S.M., Squires K.E., Hughes M.D., Grimes J.M., Demeter L.M., Currier J.S., Eron J.J., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997, 337:725-733.
4. Montaner J.S., DeMasi R., Hill A.M. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count. AIDS 1998, 12:F23-F28.
5. Egger M., Hirschel B., Francioli P., Sudre P., Wirz M., Flepp M., Rickenbach M., et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997, 315:1194-1199.
6. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
7. The first report of the national HIV/AIDS treatment registry 2003 2005, National HIV/AIDS Treatment Registry (NHATR), Clinical Research Centre, Kuala Lumpur.
8. Section AIDS HIV/AIDS prevention and control program in Malaysia 2005, Department of Public Health, Kuala Lumpur, Ministry of Health Malaysia.
9. Malaysia 2010 UNGASS country progress report: reporting period: January 2008 - December 2009 March 2010, Available at, [accessed 08.02.12]. http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmittedbycountries.
10. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992, 41:1-19.
11. Wong K.H., Chan K.C., Lee S.S. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis 2004, 39:853-860.
12. Osmand D.H. Epidemiology of disease progression in HIV May 1998, [Updated 1998], Available at, [accessed 28.02.10]. http://www.hivinsite.
13. Section AIDS, Department PH, MOH Guidelines for management of adults and adolescents with HIV infection with antiretroviral therapy 2006, Ministry of Health Malaysia, Kuala Lumpur. 2nd ed.
14. Hung C.C., Chen M.Y., Hsieh S.M., Sheng W.H., Chang S.C. Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr 2000, 24:378-385.
15. Krentz H.B., Kliewer G., Gill M.J. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005, 6:99-106.
16. Chan K.C., Wong K.H., Lee S.S. Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002. HIV Med 2006, 7:186-192.
17. UNAIDS.org UNGASS country progress report: Malaysia 2008, [updated 2008; cited]; Available at, [accessed 05.03.10]. http://data.unaids.org/pub/Report/2008/malaysia_2008_%20country_progress_report_en.pdf.
18. Rawatan AIDS di Malaysia Murah, kata pakar mStar online Thursday May 31, 2007, Available at, [accessed 24.03.10]. http://mstar.com.my/berita/cerita.asp?file=/2007/5/31/TERKINI/Mutakhir/Rawatan_AIDS_di_Malaysia_murah_kata_pakar&sec=mstar_berita.
19. Section AIDS HIV/AIDS prevention and control program in Malaysia 2009, [updated 2009; cited], Department of Public Health, Ministry of Health, Kuala Lumpur, Available at, [accessed 13.04.10]. http://www.moh.gov.my/MohPortal/index.jsp.
20. Kamarulzaman A. Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. Med J Malaysia 2005, 60:1-4.
21. Schwarcz S.K., Hsu L.C., Vittinghoff E., Katz M.H. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996. Am J Epidemiol 2000, 152:178-185.
22. Li Y., McDonald A.M., Dore G.J., Kaldor J.M. Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee. AIDS 2000, 14:2349-2354.